+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lupus"

Systemic Lupus Erythematosus Treatment Global Market Report 2024 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Immunology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 450 Pages
  • Global
From
From
From
Autoimmune Disease Testing Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Autoimmune Disease Testing Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
From
From
From
From
Market Spotlight: Systemic Lupus Erythematosus (SLE) - Product Thumbnail Image

Market Spotlight: Systemic Lupus Erythematosus (SLE)

  • Report
  • May 2021
  • 40 Pages
  • Global
Digital Health in Immunology - Thematic Research - Product Thumbnail Image

Digital Health in Immunology - Thematic Research

  • Report
  • December 2021
  • 57 Pages
  • Global
From
From
From
Loading Indicator

Lupus is an autoimmune disorder that affects the body's immune system, causing inflammation and tissue damage. It is a chronic condition that can affect multiple organs and systems in the body, including the skin, joints, and kidneys. In the context of Allergy and Immunology, Lupus is a major area of research and treatment. Diagnosis and treatment of Lupus is complex and requires a multidisciplinary approach. Treatment options include medications, lifestyle changes, and physical therapy. The Lupus market is a growing area of research and development, with a focus on improving diagnosis and treatment options. Companies are developing new drugs and therapies to improve the quality of life for those living with Lupus. Additionally, research is being conducted to better understand the underlying causes of the disease. Companies in the Lupus market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Sanofi. Show Less Read more